Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis

被引:80
作者
Bakken, JS
Aguero-Rosenfeld, ME
Tilden, RL
Wormser, GP
Horowitz, HW
Raffalli, JT
Baluch, M
Riddell, D
Walls, JJ
Dumler, JS
机构
[1] St Marys Hosp Duluth Hlth Syst, Infect Dis Sect, Duluth, MN USA
[2] St Marys Hosp Duluth Hlth Syst, Dept Educ & Res, Duluth, MN USA
[3] St Marys Hosp Duluth Hlth Syst, Dept Lab Med, Duluth, MN USA
[4] New York Med Coll, Westchester Med Ctr, Dept Pathol, Valhalla, NY 10595 USA
[5] New York Med Coll, Westchester Med Ctr, Div Infect Dis, Valhalla, NY 10595 USA
[6] New York Med Coll, Westchester Med Ctr, Dept Med, Valhalla, NY 10595 USA
[7] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
关键词
D O I
10.1086/319350
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To describe the changes that occur in blood count parameters during the natural course of human granulocytic ehrlichiosis, we designed a retrospective cross-sectional case study of 144 patients with human granulocytic ehrlichiosis and matched controls who had a different acute febrile illness. Patients from New York State and the upper Midwest were evaluated from June 1990 through December 1998. Routine complete blood counts and manual differential leukocyte counts of peripheral blood were performed on blood samples that were collected during the active illness, and values were recorded until the day of treatment with an active antibiotic drug. Thrombocytopenia was observed more frequently than was leukopenia, and the risk of having ehrlichiosis varied inversely with the granulocyte count and the platelet count. Patients with ehrlichiosis displayed relative and absolute lymphopenia and had a significant increase in band neutrophil counts during the first week of illness. Knowledge of characteristic complete blood count patterns that occur during active ehrlichiosis may help clinicians to identify patients who should be evaluated specifically for ehrlichiosis and who should receive empiric antibiotic treatment with doxycycline.
引用
收藏
页码:862 / 870
页数:9
相关论文
共 22 条
[1]   Human granulocytic ehrlichiosis: A case series from a medical center in New York state [J].
AgueroRosenfeld, ME ;
Horowitz, HW ;
Wormser, GP ;
McKenna, DF ;
Nowakowski, J ;
Munoz, J ;
Dumler, JS .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (11) :904-908
[2]   Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin [J].
Bakken, JS ;
Goellner, P ;
Van Etten, M ;
Boyle, DZ ;
Swonger, OL ;
Mattson, S ;
Krueth, J ;
Tilden, RL ;
Asanovich, K ;
Walls, J ;
Dumler, JS .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1491-1496
[3]   Clinical and laboratory characteristics of human granulocytic ehrlichiosis [J].
Bakken, JS ;
Krueth, J ;
WilsonNordskog, C ;
Tilden, RL ;
Asanovich, K ;
Dumler, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :199-205
[4]   HUMAN GRANULOCYTIC EHRLICHIOSIS IN THE UPPER MIDWEST UNITED-STATES - A NEW SPECIES EMERGING [J].
BAKKEN, JS ;
DUMLER, JS ;
CHEN, SM ;
ECKMAN, MR ;
VANETTA, LL ;
WALKER, DH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (03) :212-218
[5]   Ehrlichia phagocytophila genogroup rickettsiae in ixodid ticks from California collected in 1995 and 1996 [J].
Barlough, JE ;
Madigan, JE ;
Kramer, VL ;
Clover, JR ;
Hui, LT ;
Webb, JP ;
Vredevoe, LK .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (08) :2018-2021
[6]  
CALDWELL CW, 1995, AM J CLIN PATHOL, V103, P761
[7]  
DesVignes F, 1997, J MED ENTOMOL, V34, P379, DOI 10.1093/jmedent/34.4.379
[8]   SEROLOGIC CROSS-REACTIONS AMONG EHRLICHIA-EQUI, EHRLICHIA-PHAGOCYTOPHILA, AND HUMAN GRANULOCYTIC EHRLICHIA [J].
DUMLER, JS ;
ASANOVICH, KM ;
BAKKEN, JS ;
RICHTER, P ;
KIMSEY, R ;
MADIGAN, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) :1098-1103
[9]  
Dumler JS, 1998, ANNU REV MED, V49, P201, DOI 10.1146/annurev.med.49.1.201
[10]  
Edelman D.C., 1996, MOL DIAGN, V1, P41